Management
CEO
Dr. Simon Green.
Simon graduated with Honours as a biochemist from Monash University and completed his PhD in the field of immunology at the University of Melbourne in 1992. He has 30 years of experience in the biotechnology industry having worked at Genentech and Novartis in San Francisco, and at CSL Limited from 1998 to 2015 where he was senior Vice President in Research and Development and Manufacturing Operations.
He is a graduate of the Australian Institute of Company Directors and has experience as a non-executive Director in ASX listed companies Clover Corporation (2020-present) and Acrux (2016-2019). Simon also serves on the scientific advisory board for Imunexus Pty Ltd and is a partner at BioScience Managers, a health care investment firm.
He has served as a board member for several CSL subsidiary companies in Australia and Germany (2004-2015), the European Plasma Protein Therapeutics Association (2006-2008) and a member of the Victorian Biotechnology Advisory Council (2011-2015). Simon was also a member and acting chairman of the Victorian Government’s Northern Innovation and Investment Fund (2014-2016)
Simon is the Chief Executive Officer for Immunosis, has a broad range of managerial skills and is passionate about using science to improve the lives of patients.
Chief Scientific Officer
Professor Ben Cocks
Ben graduated from the University of Melbourne with first class Honours and a PhD in biochemisty. He has over 30 years of experience in the practical application of biotechnology and genomics in medicine and agribusiness and is Professor with the School of Applied Science Systems Biology at La Trobe University.
His discoveries include significant new pathways determining the development of parasitic, viral, and inflammatory diseases, SLAM as a key receptor important for T and B cell function, genomics application in mammals, and novel bioactive factors from cows’ milk and wallaby milk.
Ben provides scientific advice to Immunosis in the field of genomics and its application for a human diagnostic test for immune disorders.
Clinical Research and Quality Lead
Holly Pedersen
Holly is a clinical research and biomedical engineering professional with experience in healthcare software, clinical trials, and medical device development. She holds a Master’s in Biomedical Engineering with Business from the University of Melbourne and has worked across start-ups and multinational companies, managing clinical studies, regulatory compliance, and data-driven healthcare solutions.
As Clinical Research and Quality Manager at Immunosis, Holly leads clinical studies and regulatory processes for diagnostic technologies. Her previous roles at Atmo Biosciences, Seer Medical, and Siemens Healthineers have equipped her with expertise in medical device trials, AI-driven healthcare solutions, and global clinical research management.
Advisors
Professor Mel Berger, Clinical Advisor
Mel Berger is an experienced professor, medical director, and consultant who brings a wealth of knowledge and experience in diagnosis and management of patients with rare diseases including those with Primary Immunodeficiency. He holds an MD, PhD from Case Western Reserve University where he held several roles including Professor of Pediatrics, Professor of Pathology and Chief of the Allergy-Immunology Division. Mel has also served as the Chief of the Allergy/Immunology and Rheumatology Division at Rainbows Babies and Children’s Hospital and is a fellow of the American Academy of Allergy, Asthma and Immunology. He has served as a Director of the American Board of Allergy and Immunology and has held several senior medical roles in industry, including CSL Behring an Grifols.
Ms. Alison Cook, Executive Advisor
Alison is a highly accomplished business executive in biopharmaceuticals and diagnostics fields. She has global commercialisation experience in domestic and international markets and a detailed knowledge of the operational requirements to win regulatory approvals.
Alison held roles including CEO of Genetic Technologies, an ASX and NASDAQ listed genetic testing services company and senior executive roles at CSL Limited over 13 years. She holds an MSc in microbiology and graduated from the Executive Development Program at Melbourne Business School.
